Ryan Bock - SINTX Technologies Chief Officer

SINTX Technologies Management Efficiency

The company has return on total asset (ROA) of (0.4161) % which means that it has lost $0.4161 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4321) %, meaning that it created substantial loss on money invested by shareholders. SINTX Technologies' management efficiency ratios could be used to measure how well SINTX Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.51 in 2025. Return On Capital Employed is likely to drop to -1.01 in 2025. At this time, SINTX Technologies' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 272.9 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 2.5 M in 2025.

Similar Executives

Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. Sintx Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 36 people. SINTX Technologies (SINT) is traded on NASDAQ Exchange in USA. It is located in 1885 West 2100 South, Salt Lake City, UT, United States, 84119 and employs 43 people. SINTX Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

SINTX Technologies Leadership Team

SINTX Stock Performance Indicators

Additional Tools for SINTX Stock Analysis